Effect of Benralizumab in Patients With Severe Eosinophilic Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Case Series.

CONCLUSION: Usage of benralizumab in patients with SA and CRSwNP can lead to significantly improved asthma control, lung function, and sinonasal quality of life. Additionally, in this patient population, there was a subset of patients that showed a significant reduction in polyp burden.
PMID: 33302694 [PubMed - as supplied by publisher]

Source: American Journal of Rhinology and Allergy - December 10, 2020 Category: ENT & OMF Authors: Chitguppi C, Patel P, Gandler A, Murphy K, Khoury Md T, Monostra P, Bork S, Toskala E, Rabinowitz M, Rosen M, Nyquist G, Most J Tags: Am J Rhinol Allergy Source Type: research